Atalanta Sosnoff Capital, LLC Abbott Laboratories Transaction History

Atalanta Sosnoff Capital, LLC

$4.63 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$95.06 - $111.52 $788,998 - $925,616	8,300 New	8,300 $911,000
Q2 2022 Jul 14, 2022	SELL	$102.07 - $123.37 $187,094 - $226,137	-1,833 Closed	0 $0
Q1 2022 Apr 11, 2022	SELL	$114.02 - $139.04 $45.5 Million - $55.5 Million	-398,976 Reduced 99.54%	1,833 $217,000
Q4 2021 Jan 25, 2022	SELL	$115.53 - $141.46 $523,928 - $641,521	-4,535 Reduced 1.12%	400,809 $56.4 Million
Q3 2021 Oct 14, 2021	SELL	$116.66 - $129.06 $263,418 - $291,417	-2,258 Reduced 0.55%	405,344 $47.9 Million
Q2 2021 Jul 13, 2021	SELL	$105.79 - $124.53 $88,863 - $104,605	-840 Reduced 0.21%	407,602 $47.3 Million
Q1 2021 Apr 20, 2021	SELL	$108.84 - $128.23 $74,228 - $87,452	-682 Reduced 0.17%	408,442 $48.9 Million
Q4 2020 Jan 14, 2021	SELL	$105.0 - $114.42 $366,240 - $399,096	-3,488 Reduced 0.85%	409,124 $44.8 Million
Q3 2020 Oct 14, 2020	SELL	$91.64 - $111.29 $674,562 - $819,205	-7,361 Reduced 1.75%	412,612 $44.9 Million
Q2 2020 Jul 21, 2020	SELL	$76.57 - $98.0 $312,175 - $399,546	-4,077 Reduced 0.96%	419,973 $38.4 Million
Q1 2020 Apr 16, 2020	BUY	$62.82 - $91.86 $835,003 - $1.22 Million	13,292 Added 3.24%	424,050 $33.5 Million
Q4 2019 Jan 23, 2020	SELL	$78.51 - $87.4 $538,735 - $599,738	-6,862 Reduced 1.64%	410,758 $35.7 Million
Q3 2019 Oct 15, 2019	SELL	$81.84 - $88.74 $986,335 - $1.07 Million	-12,052 Reduced 2.8%	417,620 $34.9 Million
Q2 2019 Jul 15, 2019	SELL	$72.88 - $85.0 $15.1 Million - $17.6 Million	-206,547 Reduced 32.46%	429,672 $36.1 Million
Q1 2019 Apr 09, 2019	SELL	$66.22 - $80.06 $26.9 Million - $32.6 Million	-406,674 Reduced 38.99%	636,219 $50.9 Million
Q4 2018 Jan 09, 2019	SELL	$65.56 - $74.27 $178,651 - $202,385	-2,725 Reduced 0.26%	1,042,893 $75.4 Million
Q3 2018 Oct 10, 2018	SELL	$60.81 - $73.36 $1.19 Million - $1.44 Million	-19,577 Reduced 1.84%	1,045,618 $76.7 Million
Q2 2018 Jul 11, 2018	BUY	$57.57 - $63.54 $21.4 Million - $23.6 Million	371,778 Added 53.62%	1,065,195 $65 Million
Q1 2018 Apr 06, 2018	BUY	$56.27 - $63.62 $39 Million - $44.1 Million	693,417 New	693,417 $41.6 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.8 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.4 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.03 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.74 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.28 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atalanta Sosnoff Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atalanta Sosnoff Capital, LLC with notifications on news.

Account